Skip to content

Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients

Role of Magnesium Sulphate Versus Placebo on Hemodynamic Changes During Pneumoperitoneum During Laparoscopic Procedures

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07079514
Enrollment
60
Registered
2025-07-23
Start date
2025-01-06
Completion date
2025-04-21
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamics Instability, Pain After Surgery, PONV in Laparoscopic Cholocystectomies

Keywords

Pneumoperitoneum, Hemodynamics, Magnesium Sulfate, Pain, PONV

Brief summary

The goal of this triple blinded randomized control trial is to compare the effect of magnesium sulphate on the hemodynamic response during pneumoperitoneum creation, along with its impact on postoperative pain, opioid consumption, and post operative nausea vomiting (PONV) in ASA I to III patients undergoing laparoscopic cholecystectomy The main question\[s\] it aims to answer is whether the agent Magnesium Sulphate will blunt the increase in the hemodynamic response during peritoneal insufflation, and will it decrease post operative opioids consumption and prevent nausea vomiting in patients undergoing laparoscopic surgeries. 30 were given placebo and 30 were introduced with magnesium sulphate (3mg) 5 mins before insufflation. The hemodynamic such as, mean arterial pressure (MAP,) systolic (SBP) and diastolic blood pressures (DBP), heart rate (HR) were recorded pre operatively and intraoperatively with intervals of 5mins. Pain score was recorded by VAS scaling and post operative nausea vomiting (PONV) with Yes and No in post operative anesthesia unit (PACU) period.

Interventions

DRUGPlacebo

normal saline in 100ml piggy bag

DRUGMagnesium

Magnesium Sulphate will be given as doses of 20-50mg/kg in 2 -3 minutes. In order to standardize the dose in every patient we will be using 3g

Sponsors

Ziauddin University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 85 * Gender: Male /Female * ASA status I/II/III * Patients undergoing elective Laparoscopic cholecystectomy

Exclusion criteria

* Known Hypermagnesemia * Known allergy to Magnesium * Any degree of Heart Block * Patients on Calcium Channel Blockers * Known CKD/AKI

Design outcomes

Primary

MeasureTime frameDescription
Changes in Mean arterial pressures (MAP), Systolic blood pressures (SBP), Diastolic blood pressures (DBP)6 monthsLaparoscopic surgeries, such as cholecystectomy, require CO₂ insufflation to create pneumoperitoneum, which leads to increased sympathetic activity, elevated blood pressure
Changes in Heart Rate (HR)6 monthsLaparoscopic surgeries, such as cholecystectomy, require CO₂ insufflation to create pneumoperitoneum

Secondary

MeasureTime frameDescription
Pain Scores on the Visual Analog SCALE6 monthsmagnesium sulfate acts on NMDA receptor and has non opioid pain relieving properties hence we are going to assess whether there's a decrease in post operative pain

Countries

Pakistan

Contacts

STUDY_CHAIRDr Asma A Salam, MBBS, FCPS

Dr Ziauddin Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026